| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 08/27/2009 | US20090215737 Pharmaceutical Compositions - 2 |
| 08/27/2009 | US20090215736 inhibitors of apoptosis and IL-1 beta secretion; mediate cell apoptosis and inflammation; good cell penetration and pharmacokinetic properties; [3S/R(2S)]3-[2-(Carbazol-9-yl-2-oxo-ethyl)-pentanoylamino]-5-fluoro-4-oxo-pentanoic acid |
| 08/27/2009 | US20090215726 Phosphono-Pent-2-en-1-yl Nucleosides and Analogs |
| 08/27/2009 | US20090215677 Polymyxin derivatives and uses thereof |
| 08/27/2009 | US20090215673 a solution of the glycopeptide derivatives containing phosphono group which acts as antibacterial agent, a polystyrene modified with divinylbenzene bead and an acidified aqueous solution ( acetic acid or HCl) of polar solvent e.g. methanol, acetonitrile, ethanol; for purification by resin chromatography |
| 08/27/2009 | US20090215672 Cys-Rich, Cell Surface Glycoproteins |
| 08/27/2009 | US20090215667 Utility of phylloplanins as antibiotics, selective fungicides and for enhancing microbial resistance in plants |
| 08/27/2009 | US20090215151 Two-Step Immunization Procedure Against Chlamydia Infection |
| 08/27/2009 | US20090214666 Chitin microparticles and their medical uses |
| 08/27/2009 | US20090214658 Inorganic sorbent copolymer |
| 08/27/2009 | US20090214632 Inducing cellular immune responses to human papillomavirus using peptide and nucleic acid compositions |
| 08/27/2009 | US20090214617 Immobilisation and stabilisation of virus |
| 08/27/2009 | US20090214596 Nasal Vaccine |
| 08/27/2009 | US20090214589 Recombinant lentiviral vector for expression of a flaviviridae protein and applications thereof as a vaccine |
| 08/27/2009 | US20090214584 Characterization of novel lpxtg-containing proteins of staphylococcus epidermidis |
| 08/27/2009 | US20090214578 Immunostimulatory Single-Stranded Ribonucleic Acid with Phosphodiester Backbone |
| 08/27/2009 | US20090214570 Methods and compositions for immunizing against chlamydia infection |
| 08/27/2009 | US20090214566 Protective anti-glucan antibodies with preference for beta-1,3- glucans |
| 08/27/2009 | US20090214565 Anti-Interferon Alpha Monoclonal Antibodies and Methods For Use |
| 08/27/2009 | US20090214547 Binding member towards pneumolysin |
| 08/27/2009 | US20090214537 Serum Resistance Factors of Gram Positive Bacteria |
| 08/27/2009 | US20090214530 MODIFIED CpG OLIGODEOXYNUCLEOTIDE WITH IMPROVED IMMUNOREGULATORY FUNCTION |
| 08/27/2009 | US20090214476 Novel mannose-specific adhesins and their use |
| 08/27/2009 | US20090214464 Compounds for flaviviridae treatment |
| 08/27/2009 | US20090214463 Latent phase viral interleukin-10-(VII-10) and uses thereof |
| 08/27/2009 | DE102008009646A1 Drug carrier system, useful e.g. for placement through urethra to bladder, comprises active ingredient and carrier material, where carrier material is able to release ingredient on long-term basis within the bladder |
| 08/27/2009 | CA2716514A1 Hiv protease inhibitor and cytochrome p450 inhibitor combinations |
| 08/27/2009 | CA2716349A1 Methods for inhibiting drug degradation |
| 08/27/2009 | CA2716348A1 Diamide inhibitors of cytochrome p450 |
| 08/27/2009 | CA2716347A1 Amino acid inhibitors of cytochrome p450 |
| 08/27/2009 | CA2716340A1 Immunogenic influenza composition |
| 08/27/2009 | CA2715237A1 Virus-like particles as vaccines for paramyxovirus |
| 08/27/2009 | CA2714853A1 Selective poly-n-substituted glycine antibiotics |
| 08/27/2009 | CA2713187A1 Oxazolidinone derivatives |
| 08/27/2009 | CA2713182A1 Azatricyclic antibiotic compounds |
| 08/26/2009 | EP2093293A2 G-Protein coupled receptors |
| 08/26/2009 | EP2093228A1 Pyrroline-2-one derivatives against cell releasing tumor necrosis factor, preparation methods and uses thereof |
| 08/26/2009 | EP2093214A1 Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents |
| 08/26/2009 | EP2091971A2 Therapeutic targeting of escort proteins |
| 08/26/2009 | EP2091960A2 Peptide vaccine for influenza virus |
| 08/26/2009 | EP2091946A1 Piperidine derivative used for treating chemokine receptor 5 mediated diseases |
| 08/26/2009 | EP2091909A1 Water-soluble prodrugs of florfenicol and its analogs |
| 08/26/2009 | EP2091904A1 New class of terpene-derived compounds having an antibiotic activity, compositions containing the same ans uses thereof |
| 08/26/2009 | EP2091559A1 Vaccination of horses against lawsonia intracellularis |
| 08/26/2009 | EP2091549A1 Compositions and methods for treating infectious bronchitis |
| 08/26/2009 | EP2091548A1 Methods for treating and reducing the incidence of newcastle disease |
| 08/26/2009 | EP2091547A2 Composition for the treatment of gastrointestinal diseases |
| 08/26/2009 | EP2091544A2 Composition for the prevention and/or treatment of diseases associated with tnf and/or il-12 overexpression |
| 08/26/2009 | EP2091536A2 Enantiomeric compounds with antibacterial activity |
| 08/26/2009 | EP2091525A1 Potentiation of cellular immunity using histone deacetylase (hdac) inhibitors |
| 08/26/2009 | EP1856125B1 Protease inhibitor precursor synthesis |
| 08/26/2009 | EP1732525B1 Amorolfine patch for treating onychomycosis |
| 08/26/2009 | EP1530584B1 Synthetic or natural peptides binding protein phosphatase 2a, identification method and uses |
| 08/26/2009 | EP1389096B9 Delivery of opioids through an inhalation route |
| 08/26/2009 | EP1389089B1 Method and composition for solubilising a biologically active compound with low water solubility |
| 08/26/2009 | EP1297005B1 Immunisation against chlamydia pneumoniae |
| 08/26/2009 | EP1283675A4 Methods of modulating the activity of mura |
| 08/26/2009 | EP1218375B1 Pharmaceutically active sulfonyl amino acid derivatives |
| 08/26/2009 | EP1061812B1 Food products having enhanced cocoa polyphenol content and processes for producing same |
| 08/26/2009 | EP1012187B1 Chemokine peptides, variants, derivatives and analogs. their use in methods to inhibit or augment an inflammatory response |
| 08/26/2009 | CN101516914A Antibodies against CCR5 and uses thereof |
| 08/26/2009 | CN101516889A Derivatives and analogs of n-ethylquinolones and n-ethylazaquinolones |
| 08/26/2009 | CN101516884A Octahydropyrrolo [3, 4-C] pyrrole derivatives an their use as antiviral agents |
| 08/26/2009 | CN101516858A Crystalline antifungal compounds |
| 08/26/2009 | CN101516853A Quinolinone derivatives |
| 08/26/2009 | CN101516387A Caspofungin formulations |
| 08/26/2009 | CN101516385A Treatment of excessive neovascularization |
| 08/26/2009 | CN101516384A Anti-tumoral, antibacterial and antiviral pharmaceutical composition (variants) |
| 08/26/2009 | CN101516365A Inhibitors of undecaprenyl pyrophosphate synthase |
| 08/26/2009 | CN101514335A Expression and purification of influenza virus polymerase PA and crystal structure of complex of polypeptides at amino terminal of PA, carboxyl terminal of PA and amino terminal of PB1 |
| 08/26/2009 | CN101514334A Chicken infectivity bronchitis virus attenuated vaccine strain and application thereof |
| 08/26/2009 | CN101514229A Human interferon alpha derivative and polyethylene glycol modified substance thereof |
| 08/26/2009 | CN101514228A N-terminal modified human thymosin alfa 1 compound and preparation method thereof |
| 08/26/2009 | CN101514200A Compound of aztreonam and a synthetic method thereof |
| 08/26/2009 | CN101513527A Bivalent inactivated vaccine against gosling plague and goose paramyxovirus disease and preparation method thereof |
| 08/26/2009 | CN101513524A Alpha-interferon dry powder inhalant for pigs and method for producing same |
| 08/26/2009 | CN101513506A Medicament for treating tinea manus and pedis |
| 08/26/2009 | CN101513488A Traditional Chinese medicine compound for treating hepatitis |
| 08/26/2009 | CN101513485A Medicament for treating tinea |
| 08/26/2009 | CN101513471A Food prescription for treating bacillary dysentery |
| 08/26/2009 | CN101513468A Oral medicament for treating herpes zoster |
| 08/26/2009 | CN101513447A Medicament for treating dermatitis and tinea |
| 08/26/2009 | CN101513444A Medicine for treatment of aftosa |
| 08/26/2009 | CN101513441A Pure traditional Chinese medicine ointment for remedying burn and scald wound and infective trauma and preparation method thereof |
| 08/26/2009 | CN101513440A Sonchus plant extract and application thereof in preparing medicament for curing skin diseases |
| 08/26/2009 | CN101513435A Biological preparation formed by utilizing fermentation process for India pokeberry and preparation method |
| 08/26/2009 | CN101513433A External ointment for treating herpes zoster |
| 08/26/2009 | CN101513409A Pharmaceutical composition of cephalexin |
| 08/26/2009 | CN101513406A Stable S-(-)-nadifloxacin L-arginine salt composition, preparation method and application thereof |
| 08/26/2009 | CN101513405A Use of chemotherapeutic agents |
| 08/26/2009 | CN101513402A Antiviral agent |
| 08/26/2009 | CN101513396A Method for preparing ciprofloxacin hydrochloride time-release capsule |
| 08/26/2009 | CN100532559C Virus envelope vector for gene transfer |
| 08/26/2009 | CN100532548C Method of increasing yield of human papilloma virus L1 albumen pronucleus expression |
| 08/26/2009 | CN100532383C Cefoperazone sodium novel crystal form and its preparation method |
| 08/26/2009 | CN100531799C Preparation for enhancement of action of anti-infective agent and method |
| 08/26/2009 | CN100531757C Medicinal composition for treating anemopyretic cold and its preparation method |
| 08/26/2009 | CN100531753C Composition for treating hepatitis c |
| 08/26/2009 | CN100531748C Sambucus Chinensis extract and its preparing method |
| 08/26/2009 | CN100531745C Application of 'Kudiezi' injection in use for preparing antiviral remedy |